Figure 2. Primary endpoint in the intention-to-treat population at 1-year follow-up: (A) primary endpoint, (B) efficacy outcomes (cardiac death, myocardial infarction, stent thrombosis, and ischemic stroke), and (C) safety outcomes (BARC ≥2 bleeding events).

CI = confidence interval; HR = hazard ratio; NSTE-ACS = non-ST-segment elevation acute coronary syndrome; STEMI = ST-elevation myocardial infarction.